Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » About Us » Our Staff » Andrew P. Han

Andrew P. Han

Editor
Phone Number
+1-212-651-5640
Email
[email protected]

Andrew Han covers breaking news for GenomeWeb. He tracks companies in the sequencing and diagnostic markets.

Articles Authored by Andrew P. Han

Jun 26, 2020

Iowa Startup FBB Biomed Pursues RNA Blood Test to Predict COVID-19 Disease Severity

Premium

FBB Biomed, cofounded by a diagnostics industry veteran, is attempting to develop a blood RNA test to predict COVID-19 disease severity.

Jun 22, 2020

Stanford Spinout Levitas Bio to Launch Magnetic Levitation Cell Separation Platform

Premium

The Bay Area startup is offering a no-touch method to separate cell populations for downstream analysis in genomics and synthetic biology applications.

Jun 15, 2020

Roswell Biotechnologies Enters Critical Phase of Industrializing Molecular Sensor Production

Premium

The sequencing instrument developer is in the process of scaling and optimizing its silicon chips and plans to offer its platform by the end of next year.

Jun 15, 2020

Genome In a Bottle Consortium Releases Structural Variant Calling Benchmark Data

Premium

The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods.

Jun 11, 2020

Avida Biomed Developing Hybridization-Based Methylation Sequencing Panels for Cancer Dx

Premium

The firm touts a new hybridization probe design, which it says will enable small, focused panels that reduce sequencing costs and assay time.

Jun 09, 2020

Judge Allows Whistleblower Suit Against Myriad Genetics to Proceed

Premium

In January a federal court unsealed a False Claims Act suit from an industry insider that alleges a Myriad subsidiary engaged in a fraudulent kickback scheme.

Jun 02, 2020

10x Genomics, Collaborators Develop Targeted Single-Cell Gene Expression Methods

Premium

These hybrid capture-based methods target gene transcripts of interest, which could shrink sequencing costs for some experiments by as much as 90 percent.

May 29, 2020

Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering

Premium

The infectious disease testing firm has developed a sequencing-based coronavirus assay, which it plans to commercialize through its sister firm BioID Genomics. 

May 21, 2020

Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

Premium

Single-cell analysis, next-generation sequencing, and synthetic DNA have all been crucial to efforts to find antibodies that could neutralize SARS-CoV-2.

May 13, 2020

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19

Premium

The diagnostics firm is conducting a 1,000-person study to find T cell profiles associated with the immune response to COVID-19 and recovery from the disease.

The Scan

Working Out the Effect

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Increased Genetic Privacy in Florida

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

Attention-Grabbing in Two Ways

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.